Zevra Therapeutics (ZVRA) Other Non-Current Assets (2014 - 2026)

Zevra Therapeutics (ZVRA) has 13 years of Other Non-Current Assets data on file, last reported at $143000.0 in Q1 2026.

• Quarterly Other Non-Current Assets fell 51.19% year-over-year to $143000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $143000.0 (down 51.19% YoY) and the FY2025 annual result came in at $143000.0, down 62.76% from the prior year.
• Other Non-Current Assets steadied at $143000.0 in Q1 2026, from $143000.0 in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $1.8 million in Q1 2024 to a low of $53000.0 in Q4 2022.
• A 5-year average of $356466.7 and a median of $153000.0 in 2025 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets sank 87.9% — and 2024, when it jumped 3269.81%.
• Tracing ZVRA's Other Non-Current Assets over 5 years: stood at $53000.0 in 2022, then soared by 77.36% to $94000.0 in 2023, then soared by 308.51% to $384000.0 in 2024, then sank by 62.76% to $143000.0 in 2025, then changed by 0.0% to $143000.0 in 2026.
• The last three Other Non-Current Assets figures came in at $143000.0 (Q1 2026), $143000.0 (Q4 2025), and $153000.0 (Q3 2025), per Business Quant data.